Skip to main content
. Author manuscript; available in PMC: 2018 Oct 5.
Published in final edited form as: Genet Med. 2000 Jul-Aug;2(4):232–241. doi: 10.1097/00125817-200007000-00006

Table 3.

Clinical data of affected individuals*

Case Age (y) Sex PDB LGMD AgeDx PDB(y) AgeDx LGMD (y) Treatment Activity Level
1 48 F + + 34 44 None Difficulty going up stairs and raising arms, back/leg pain, lumbar lordosis, wide based gait
2 47 M + 45 None Weakness in proximal arm and leg muscles
3 49 F + + 44 48 Previous bisphosphonates Difficulty climbing stairs, lifting arms, extremity atrophy of extremities, lordotic posture, waddling gait
4 57 M + + 42 54 Calcitonin and bisphosphonates Walks slowly with cane, severe pain and tenderness in spine and hip
5 33 M + - 31 - Analgesics and calcitonin Walks slowly with a limp, tenderness in back, pain in hip
6 50 M + + 38 38 None Bedridden for several months, left side hemiparesis from stroke
7 47 F + + 45 45 Alendronate, cyclobenzaprine Difficulty sitting, getting up from chair, back pain and weakness of the arms and hips
8 46 M + - 40 None Unable to run, difficulty with stairs
9 64 M + + 37 40 None Wheelchair bound, loss of sensation in extremities
10 59 M + + UK 51 None Bedridden 3 y prior to death, winging of the scapulae, weakness of trunk & lower extremities
11 61 M + + 61 UK None Difficulty walking, pain in spine and pelvis and femur
MEAN 50.9 3F/8M 9 10 41.5 45.6
*

+ = present; − = absent; UK = unknown